NCT05805059 is a NA clinical trial of Control Contact Lens (stenfilcon A) in Myopia, sponsored by CooperVision, Inc..

Who is sponsoring NCT05805059?

NCT05805059 is sponsored by CooperVision, Inc..

What drugs are being tested in NCT05805059?

Interventions in NCT05805059: Control Contact Lens (stenfilcon A), Test Contact Lens (senofilcon A).

Is NCT05805059 still recruiting?

NCT05805059 is currently completed. Last updated 26 September 2024.

Are results published for NCT05805059?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-09-26 · How we verify

NCT05805059

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

Completed NA Results posted Last updated 26 September 2024

What this trial tests

NA trial testing Control Contact Lens (stenfilcon A) in Myopia in 68 participants. Completed in 20 June 2023.

Timeline

14 April 2023

Primary endpoint
20 June 2023

20 June 2023

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	68
Start date	14 April 2023
Primary completion	20 June 2023
Estimated completion	20 June 2023
Sites	4 locations across Canada, United States

Drugs / interventions tested

Control Contact Lens (stenfilcon A)
Test Contact Lens (senofilcon A)

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

CooperVision, Inc.

Who can join

Adults 18 to 35, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Lens Handling on Removal Primary · Collected once on day 6 at the end of wear

Lens Handling on Removal, using a 0-100 scale (0=Very difficult, 100=Very easy)

Group	Value	95% CI
Control Contact Lens	95	± 12
Test Contact Lens	94	± 11

Adverse events — posted to ClinicalTrials.gov

Time frame: Duration of the study, approximately 2 weeks.. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Control Contact Lens

Serious: 0/68 (0%)

Deaths: 0/68

Test Contact Lens

Serious: 0/68 (0%)

Deaths: 0/68

Other adverse events (2 terms — click to expand)

Reaction	System	Control Contact Lens	Test Contact Lens
eye twitching	Eye disorders	—	—
Hyperemia	Eye disorders	—	—

Data from ClinicalTrials.gov NCT05805059 adverse events section.

Sponsor's own description

The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other CooperVision, Inc. trials

Trials by the same sponsor.

NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05805059 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
Last refreshed: 26 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05805059.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing